Rockefeller Capital Management
CNMD icon

Rockefeller Capital Management’s CONMED CNMD Stock Holding History

Rockefeller Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.1K Buy
1,388
+345
+33% +$14K ﹤0.01% 3287
2025
Q4 		$42.4K Buy
1,043
+341
+49% +$14.8K ﹤0.01% 3145
2025
Q3 		$33K Buy
+702
New +$36.4K ﹤0.01% 3106
2023
Q1 		– Sell
-44
Closed -$3K – 2329
2022
Q4 		$3K Sell
44
-44
-50% -$3.65K ﹤0.01% 3443
2022
Q3 		$6K Sell
88
-29
-25% -$2.74K ﹤0.01% 3265
2022
Q2 		$10K Buy
117
+23
+24% +$2.76K ﹤0.01% 3107
2022
Q1 		$13K Sell
94
-66
-41% -$9.22K ﹤0.01% 2906
2021
Q4 		$21K Buy
160
+125
+357% +$17.7K ﹤0.01% 2623
2021
Q3 		$3K Buy
35
+20
+133% +$2.62K ﹤0.01% 3318
2021
Q2 		$2K Buy
15
+6
+67% +$821 ﹤0.01% 3231
2021
Q1 		$1K Buy
+9
New +$1.08K ﹤0.01% 3164
2019
Q3 		– Sell
-129
Closed -$11K – 1926
2019
Q2 		$11K Buy
+129
New +$10.6K ﹤0.01% 1197

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Rockefeller Capital Management's CNMD Position: Q1 2026 in Review

Rockefeller Capital Management increased its CONMED (CNMD) stake by 33% in Q1 2026, buying an estimated $14K and bringing the position to 1,388 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

Rockefeller Capital Management first reported a position in CNMD in Q2 2019 and has held it in 12 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Rockefeller Capital Management held 1,388 shares of CONMED worth $49.1K as of Q1 2026.
  • Rockefeller Capital Management bought 345 CONMED shares in Q1 2026, an estimated $14K.
  • CONMED made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3287 holding.
  • Rockefeller Capital Management first reported a position in CONMED in Q2 2019 and has held it in 12 quarters since.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.